Pharmaceuticals

Imperial College London is a hive of activity in drug discovery and development. Imperial hosts some of the world’s leading scientists as well as the affiliation with Imperial NHS trust, one of the largest academic health systems in Europe.

Based on these cutting edge capabilities, ICON has a proven record in assisting pharmaceutical companies and CROs to develop successful, ground-breaking medicines.

Our consultants are key opinion leader physicians and globally renowned researchers, who are committed to translating their expertise into practice in order to push the boundaries of drug development.

We have helped clients solve a range of problems:

 

SCIENTIFIC AND REGULATORY ADVICE AND PROTOCOL ASSISTANCE

Our academics have offered scientific, regulatory advice as well as assistance with clinical trial protocols in all therapeutic classes including rare diseases.`

 

PRE-CLINICAL DEVELOPMENT

Validated disease models in multiple therapeutic areas, high throughput screening, assays, pre-clinical species PK/PD, imaging, medicinal chemistry, structural synthesis pathways and lead optimisation strategy.

 

VACCINE DEVELOPMENT

Identification of antigens, reverse vaccinology, vaccine challenge tests for RSV, malaria and influenza.

 

MOLECULAR DIAGNOSTICS UNIT (MDU)

The CPA-accredited Molecular Diagnostic Unit (MDU) provides fast, accurate diagnostic tests for the management of infectious and genetic diseases using latest technology, including next generation sequencing and UPLC. Through ongoing research and development of new diagnostic methods it strives to remain ahead of the field in diagnostic testing and clinical monitoring.

The MDU supports the HIV and HTLV trials of the Clinical Trials Centre and patient management for The National Centre for Human Retrovirology and Imperial College Healthcare Trust.

Work to date has been centred on HIV, hepatitis viruses and sexually transmitted infections – but the clinical requirements of other clients can be catered for, click for more details

 

 

ACCESS TO FACILITIES

Genomics, biomarker discovery, high throughput mass spec, NMR, X-ray crystallography, advanced PET, advanced MRI, functional MRI and quantitative image analysis using AI.

Whether you need help with pre/clinical development or access to cutting edge validated assays and disease models, we can find the right people to help you solve a problem flexibly and responsively.

Advisory services

Product design, research methods, data analysis, technology evaluation for investment, technological innovation, patent evaluation, prototype and protocol development, policy, cyber security and more. Assisting museums, writers, film makers and artists to ensure creations scientifically sound.

Expert insight

Membership of Scientific Advisory Boards and Technical Panels, advice and guidance on drug development programmes, thought leadership, conference speakers, literature reviews and provision of foresight.

Analysis and testing

Use of the world-class specialist facilities and technicians at Imperial for projects ranging from aerodynamic measurements and medical imaging to structural testing and analysis.

Our consultants are world-leading experts in their field, committed to on-going research in business, finance, computing, engineering, medicine and science.

Who to contact:

Poh-Choo Pang

Poh-Choo Pang

Engagement Manager

For Clinical Sciences, Medicine, Chemistry, Bio-Sciences, Biochemistry, Bio-tech, Ecology, Microbiology, Physics

Tel: +44 (0)20 7594 6557

Email me

All areas of expertise:

Related Insights

The search for a cure

The search for a cure

For the past 25 years Imperial has been at the heart of the hunt for a cure for HIV. This is the story of that search – of the highs, the lows, the setbacks and the breakthroughs. read more

Imperial’s response to COVID-19

Imperial’s response to COVID-19

Experts across a wide range of disciplines have been and are continuing to to keep government and society informed about COVID-19, save lives through vaccines and testing - and protect precious workforces like the NHS. read more

Carbon capture and storage

Carbon capture and storage

Imperial researchers are working to make CCS more efficient, fine-tune our understanding of risk, and develop economics and policy proposals. read more

Related case studies

Neuropathic pain drug development

Neuropathic pain drug development

Our consultants shared their expertise in neuropathic pain area treatments to support Spinifex’s drug discovery and development programs. read more

Imperial College London Diabetes Centre

Imperial College London Diabetes Centre

The Imperial College London Diabetes Centre was established in Abu Dhabi, in 2006, by Mubadala and experts from Imperial to address the demand for diabetes care in the UAE. With continued support from Imperial, the centre now operates three branches across Abu Dhabi and Al Ain and public health initiatives. read more

Scottish health service delivery and performance

Scottish health service delivery and performance

Our consultants shared their expertise in acute medicine and experience of working for governmental organisations and the NHS to help NHS Scotland and the Scottish Government to improve efficiency and quality in the Scottish health service. read more

Latest news

Groundbreaking analysis reveals a fully flexible energy system could cut the cost of reaching net zero by up to £16.7bn a year in 2050

Groundbreaking analysis reveals a fully flexible energy system could cut the cost of reaching net zero by up to £16.7bn a year in 2050

Analysis led by the Carbon Trust and Prof Strbac and supported by Bryt Energy, EDF, Greater London Authority, IGEM, Kiwi Power, Low Carbon Contracts Company, SBM Offshore, SP Energy Networks, Statera Energy, Scottish and Southern Electricity Networks (SSEN), UK Power Networks and Western Power Distribution. read more

Global methane emissions rising at alarming rate

Global methane emissions rising at alarming rate

Our analysis shows that increased human activities are the most likely cause advises Dr Apostolos Voulgarakis. The Global Methane Budget charts the sources and sinks of global methane from our atmosphere. Its 2016 update shows that methane in the atmosphere has increased by 150 percent since the year 1750, and is responsible for 20 percent of the global warming produced by all greenhouse gases so far. read more

Investing in pumped hydro storage could save up to £690m a year on pathway to net zero

Investing in pumped hydro storage could save up to £690m a year on pathway to net zero

Study by independent researchers for SSE Renewables found that just 4.5GW of new long duration pumped hydro storage with 90GWh of storage could save up to £690m per year in energy system costs by 2050, as the UK transitions to a net-zero carbon emission system. read more